ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
AstraZeneca at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
AstraZeneca brings 8 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 3221. Its program centres on lupus, covering anifrolumab in real-world use and by intravenous and subcutaneous dosing, glucocorticoid use, and innate immune signalling. It also covers systemic sclerosis and treatment needs in eosinophilic granulomatosis with polyangiitis.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
AstraZeneca Wilmington, DE | |
Global pharmaceutical company developing and commercializing prescription medicines. | Booth Exhibiting at Booth 3221 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Industry Sun Nov 8 11:30am–12:15pm Systemic Sclerosis: Connecting Clinical Insights, Biology, and Future Research Industry Sun Nov 8 5:30pm–7:30pm Connecting the Evidence: Translational Science, Clinical Trials, and Real-World Data in SLE Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at AstraZeneca
Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction